Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorma Isola

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|May 24, 2019
Breast cancer outcome prediction with tumour tissue images and machine learningRiku Turkki, Dmitrii Byckhov, Mikael Lundin, et al.
Gynecologic Oncology|March 30, 2004
Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometryMisa Raitanen, Maria J Worsham, Taina Lakkala, et al.
Breast Cancer Research : BCR|February 1, 2007
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancersMervi Jumppanen, Sofia Gruvberger-Saal, Päivikki Kauraniemi, et al.
International Journal of Cancer|November 13, 2008
Biological aggressiveness of prostate cancer in the Finnish screening trialMarita Laurila, Teuvo L J Tammela, Anssi Auvinen, et al.
Cancer Letters|July 4, 2025
Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugatesNarjes Yazdi, Negar Pourjamal, Riku Katainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracilAngelo Di Leo, David Gancberg, Denis Larsimont, et al.
Iscience|June 9, 2022
MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levelsElisa Närvä, Maria E Taskinen, Sergio Lilla, et al.
Breast Cancer Research : BCR|September 15, 2011
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort studyHarri Sihto, Johan Lundin, Mikael Lundin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinomaSofia K Gruvberger-Saal, Pär-Ola Bendahl, Lao H Saal, et al.
Cancer Research|October 3, 2007
Association of Wwox with ErbB4 in breast cancerRami I Aqeilan, Valentina Donati, Eugenio Gaudio, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|May 24, 2019
Breast cancer outcome prediction with tumour tissue images and machine learningRiku Turkki, Dmitrii Byckhov, Mikael Lundin, et al.
Gynecologic Oncology|March 30, 2004
Characterization of 10 vulvar carcinoma cell lines by karyotyping, comparative genomic hybridization and flow cytometryMisa Raitanen, Maria J Worsham, Taina Lakkala, et al.
Breast Cancer Research : BCR|February 1, 2007
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancersMervi Jumppanen, Sofia Gruvberger-Saal, Päivikki Kauraniemi, et al.
International Journal of Cancer|November 13, 2008
Biological aggressiveness of prostate cancer in the Finnish screening trialMarita Laurila, Teuvo L J Tammela, Anssi Auvinen, et al.
Cancer Letters|July 4, 2025
Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugatesNarjes Yazdi, Negar Pourjamal, Riku Katainen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracilAngelo Di Leo, David Gancberg, Denis Larsimont, et al.
Iscience|June 9, 2022
MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levelsElisa Närvä, Maria E Taskinen, Sergio Lilla, et al.
Breast Cancer Research : BCR|September 15, 2011
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort studyHarri Sihto, Johan Lundin, Mikael Lundin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinomaSofia K Gruvberger-Saal, Pär-Ola Bendahl, Lao H Saal, et al.
Cancer Research|October 3, 2007
Association of Wwox with ErbB4 in breast cancerRami I Aqeilan, Valentina Donati, Eugenio Gaudio, et al.
Pageof 15